Charles S Berkman Ligand Pharmaceuticals Inc (LGND) insider trading activity

Charles S Berkman is of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 23,825 shares of LGND, which is worth approximately $2.73 Million. The most recent transaction as insider was on Nov 01, 2022, when has been sold 11,944 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.8K

0% 3M change

0% 12M change

Total Value Held $2.73 Million

Charles S Berkman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2022	SELL Sale (or disposition) back to the issuer	-	11,944 Reduced 33.39%	23,825 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	5,375 Added 13.06%	35,769 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$195,167 $123.68 p/Share	1,578 Reduced 4.94%	30,394 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$245,094 $113.68 p/Share	2,156 Reduced 6.32%	31,972 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	6,237 Added 15.45%	34,128 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$175,047 $172.46 p/Share	1,015 Reduced 3.51%	27,891 Common Stock
Feb 04 2021	SELL Open market or private sale	$3,230,314 $178.5 p/Share	18,097 Reduced 38.5%	28,906 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	3,491 Added 6.91%	47,003 Common Stock
Jan 25 2021	SELL Payment of exercise price or tax liability	$208,964 $156.06 p/Share	1,339 Reduced 2.99%	43,512 Common Stock
Jan 25 2021	BUY Grant, award, or other acquisition	-	3,736 Added 7.77%	44,342 Common Stock

Also insider at

AHPAW

Avista Public Acquisition Corp. II Financial Services

Chief Legal Officer

CSB